| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 208 | 22.309 | 35.763 | 39.662 | 35.639 | 36.194 |
| Total Income - EUR | - | - | - | - | 208 | 22.309 | 35.763 | 39.662 | 35.639 | 36.194 |
| Total Expenses - EUR | - | - | - | - | 209 | 1.003 | 678 | 693 | 8.176 | 10.559 |
| Gross Profit/Loss - EUR | - | - | - | - | -1 | 21.305 | 35.085 | 38.969 | 27.463 | 25.636 |
| Net Profit/Loss - EUR | - | - | - | - | -7 | 20.655 | 34.012 | 37.803 | 23.157 | 24.604 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Sibriomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 86 | 48 | 12 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 102 | 21.269 | 54.738 | 54.437 | 27.623 | 28.383 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 31.286 | 0 | 0 |
| Cash | - | - | - | - | 102 | 21.269 | 54.738 | 23.151 | 27.623 | 28.383 |
| Shareholders Funds | - | - | - | - | 35 | 20.689 | 54.242 | 37.852 | 25.518 | 26.854 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 154 | 628 | 508 | 16.586 | 2.225 | 1.528 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sibriomed S.r.l.